Asston Pharmaceuticals Limited Press Release Sep 07 2026
Filed with BSE · · 25 pages · English
Summary by 6ix AI
Asston Pharmaceuticals Limited has issued a notice for its seventh Annual General Meeting, scheduled to be held through video conferencing. The meeting will cover the adoption of financial statements and the appointment of directors and auditors. Additionally, it includes proposals for increasing the remuneration of key executives.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Asston Pharmaceuticals Limited on 6ix
Earlier from Asston Pharmaceuticals
- Asston Pharmaceuticals Limited Press Release Sep 05 2026
- Asston Pharmaceuticals Limited Press Release Sep 04 2026
- Asston Pharmaceuticals Limited Press Release Sep 01 2026
- Asston Pharmaceuticals Limited Press Release Aug 31 2026
- Asston Pharmaceuticals Limited Press Release Jul 31 2026
Later from Asston Pharmaceuticals
- Asston Pharmaceuticals Limited Press Release Sep 27 2026
- Asston Pharmaceuticals Limited Press Release Sep 29 2026
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
- Announcement under Regulation 30 (LODR)-Change in Management
Follow Asston Pharmaceuticals into a list and get an email when it puts out news.
Follow Asston Pharmaceuticals